Valuation & Market

Zefiro Methane founder accuses the board of entrenchment tactics, setting the stage for a critical BCSC hearing that will shape the company's future.

At NYFW, Christian Cowan traded spectacle for sensuality. Discover his new intimate vision and the rising model, Maria Klaumann, chosen to embody it.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.

After a brutal 2024 and a massive strategy shift, all eyes are on Stellantis's 2025 earnings. Will the numbers justify its painful pivot away from EVs?

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

The AI and GPU infrastructure firm has adopted a shareholder rights plan, a defensive move to thwart hostile takeovers and control its destiny.

Honeywell's $1.19 quarterly dividend highlights its robust financial health and commitment to shareholders, backed by a strong forecast for 2026.

Tacoma-based Columbia Banking System holds its quarterly dividend at $0.37, reflecting strong earnings and strategic growth in a complex regional market.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

With massive data center orders but cautious guidance, the industrial giant's upcoming conference talks are a key test of investor confidence.

National Storage Affiliates Trust declared a steady dividend, but a look at its financial performance reveals a complex picture for investors.

As Perimeter preps its year-end results, investors are watching if its aggressive diversification can overcome operational hurdles and justify its new shape.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

A new plant-derived drug shows promise in preventing prostate cancer and improving cholesterol, but the company faces significant financial hurdles ahead.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

Chaim Indig’s third honor as a Top 50 CEO underscores Phreesia's deep impact on patient care, backed by major growth and market leadership.

PXG adds LPGA pro Olivia Cowan to its roster, a move highlighting the brand's focus on custom fitting, performance, and the booming women's golf market.

Amid a record backlog and major program milestones, CEO Kathy Warden is set to detail the defense giant's strategy at Citi's upcoming tech and mobility event.